In MDS, del(5q) was associated with a low-risk of leukemic evolution, unless it was accompanied by a mutation of TP53[1], or by a complex karyotype (presence of ≥ 1 additional chromosomal abnormalities)[2,3]. The gene discussed is TP53; the disease is myelodysplastic syndrome.